GSK Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: May 1, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on May 1, 2025, that it purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine disclosure of share repurchases, which is common for publicly traded companies.
Key Players & Entities
- GSK plc (company) — Registrant
- Citigroup Global Markets Limited (company) — Corporate stockbroker
- May 1, 2025 (date) — Date of announcement and purchase
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing reports on GSK plc's transaction in its own shares, specifically the purchase of ordinary shares.
Who is acting as GSK's stockbroker for these transactions?
Citigroup Global Markets Limited is acting as GSK's corporate stockbroker for these share purchases.
On what date did GSK announce the share purchase?
GSK announced the share purchase on May 1, 2025.
What type of shares did GSK purchase?
GSK purchased its own ordinary shares of 31¼ pence each.
Does the filing specify the number of shares purchased or the total cost?
No, the filing states that GSK purchased 'the following number of the Company's ordinary shares' but does not provide the specific quantity or the total dollar amount.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 1, 2025 regarding GSK plc (GLAXF).